Literature DB >> 21228463

Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization.

Takeshi Ishii1, Tatsuya Ichikawa, Kanako Minoda, Koji Kusaka, Sohei Ito, Yukiko Suzuki, Mitsugu Akagawa, Kazuki Mochizuki, Toshinao Goda, Tsutomu Nakayama.   

Abstract

Human serum albumin (HSA) contributes to the stabilization of (-)-epigallocatechin gallate (EGCg) in serum. We characterize in the present study the mechanisms for preventing EGCg oxidation by HSA. EGCg was stable in human serum or buffers with HSA, but (-)-epigallocatechin (EGC) was unstable. We show by comparing EGCg and EGC in a neutral buffer that EGCg had a higher binding affinity than EGC. This indicates that the galloyl moiety participated in the interaction of EGCg with HSA and that this interaction was of critical importance in preventing EGCg oxidation. The binding affinity of EGCg for HSA and protein carbonyl formation in HSA were enhanced in an alkaline buffer. These results suggest the reversible covalent modification of EGCg via Schiff-base formation, and that the immobilization of EGCg to HSA, through the formation of a stable complex, prevented the polymerization and decomposition of EGCg in human serum.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228463     DOI: 10.1271/bbb.100600

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  25 in total

1.  Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).

Authors:  Nataliya Popovych; Jeffrey R Brender; Ronald Soong; Subramanian Vivekanandan; Kevin Hartman; Venkatesha Basrur; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  J Phys Chem B       Date:  2012-03-07       Impact factor: 2.991

2.  Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 3.  Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.

Authors:  Sinosh Skariyachan; Vaishnavi Sneha Sridhar; Swathi Packirisamy; Supreetha Toplar Kumargowda; Sneha Basavaraj Challapilli
Journal:  Folia Microbiol (Praha)       Date:  2018-01-19       Impact factor: 2.099

4.  Effect of (-)-epigallocatechin-3-gallate on glucose-induced human serum albumin glycation.

Authors:  M Li; A E Hagerman
Journal:  Free Radic Res       Date:  2015-03-20

5.  The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism.

Authors:  Kathrin Andrich; Jan Bieschke
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment.

Authors:  Marcel Stenvang; Morten S Dueholm; Brian S Vad; Thomas Seviour; Guanghong Zeng; Susana Geifman-Shochat; Mads T Søndergaard; Gunna Christiansen; Rikke Louise Meyer; Staffan Kjelleberg; Per Halkjær Nielsen; Daniel E Otzen
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

Review 7.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

Review 8.  Natural compounds may open new routes to treatment of amyloid diseases.

Authors:  Jan Bieschke
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 9.  Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.

Authors:  Beatrix Peter; Szilvia Bosze; Robert Horvath
Journal:  Eur Biophys J       Date:  2016-06-16       Impact factor: 1.733

10.  Partial peptide of α-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of α-synuclein.

Authors:  Wataru Yoshida; Natsuki Kobayashi; Yasuhiko Sasaki; Kazunori Ikebukuro; Koji Sode
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.